Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On Monday 22 July, Professor Vanessa Ferreira gave her inaugural lecture titled, The investigation of cardiovascular diseases using MRI parametric mapping: The Past, Present and Future.

Professor Vanessa Ferreira delivers her inaugural lecture

The event was attended by over 60 RDM colleagues who heard Vanessa speak passionately about her 15 years of research on the use of cardiovascular magnetic resonance (CMR) in the study of heart disease. Her work focuses on the CMR characterisation of myocardial tissue and how parametric mapping techniques, specifically myocardial T1-mapping, can be developed to gain a greater understanding of heart disease. T1-mapping provides high resolution, pixel-wise quantitative maps of body tissue based on the tissue’s T1 relaxation time, which is an MR property that can be measured using MRI scans. The heart has a range of normal T1 values, values outside of which can indicate heart disease. T1-mapping generates a map of the heart which can locate small areas of disease in a quantitative manner. The technique examines the heart more thoroughly beyond what can be done using conventional MRI scans, and without the need for invasive contrast injections.

Vanessa Ferreira with Keith Channon and Stefan Neubauer

Professor Ferreira was awarded the title of Full Professor of Cardiovascular Medicine in the University’s 2023 Recognition of Distinction exercise.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.